Stay updated on XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page.

Latest updates to the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe record history now shows Revision: v3.5.4, replacing the previous v3.5.3 entry. This reflects an updated revision in the study's history without changing the visible study data.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s footer/source revision changed from v3.5.2 to v3.5.3, indicating an update to the ClinicalTrials.gov interface/version rather than any modification to the study record itself.SummaryDifference0.1%

- Check46 days agoChange DetectedThe study record history now shows an added Revision: v3.5.2 and a deleted Revision: v3.5.0.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry v3.5.0 was added to the Record History, and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check82 days agoChange DetectedThe history now shows a new revision entry v3.4.3. The previous revision v3.4.2 has been removed.SummaryDifference0.1%

- Check111 days agoChange DetectedRevision: v3.4.2 was added; the notice about government funding lapses and the older Revision: v3.4.1 were removed from the history.SummaryDifference0.9%

Stay in the know with updates to XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page.